NEPHROS, INC. Gain (Loss) on Extinguishment of Debt
NEPHROS, INC. (NEPH) reported Gain (Loss) on Extinguishment of Debt of $482.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2023-03-23
- NEPHROS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was $0.00.
- NEPHROS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-09-30 was $0.00.
- NEPHROS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-06-30 was $0.00.
- NEPHROS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-03-31 was $482.00K.
- NEPHROS, INC. gain (loss) on extinguishment of debt for fiscal 2021 was $482.00K.
- NEPHROS, INC. gain (loss) on extinguishment of debt for fiscal 2018 was -$199.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | $0.00 derived: sum of 3 quarters · filed 2023-03-23 | $482.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-15 | $0.00 derived: sum of 2 quarters · filed 2022-11-15 | $482.00K 10-Q · filed 2022-11-15 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $482.00K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $482.00K 10-Q · filed 2022-05-05 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | -$199.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | -$199.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$199.00K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$199.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |